Back

Rosen Law Firm investigates Disc Medicine securities claims after 22% stock drop

Verifying
  • Rosen Law Firm investigates potential securities claims involving Disc Medicine shareholders.
  • Disc Medicine shares fell 22% on February 13, 2026, after FDA action.
  • FDA issued a Complete Response Letter concerning Disc Medicine’s bitopertin program.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.